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Purpose: Epilepsy can develop at any age for reasons that remain poorly understood. The aim of this
study was to determine the impact of a family history of epilepsy (FHE) on the incidence and recurrence
of seizures.
Methods: This retrospective study was conducted in Aseer central hospital, Abha, Saudi Arabia between
January and June 2012. The medical records of 420 patients were analyzed to test the impact of FHE on
the risk factors, etiology and diagnosis of epilepsy determined by magnetic resonance imaging (MRI) and
electroencephalography (EEG).
Results: 420 patients were studied. Idiopathic epilepsy was seen in 140 patients (33%), symptomatic in
152 (36%), and cryptogenic in 128 patients (30%). FHE was seen in 113 patients (27%), which was
associated with younger at the disease onset (15 years vs 20 years, p < 0.05). Idiopathic epilepsy was
seen more in patients with FHE (43% vs 30%, p value <0.05), and generalized seizures (primary or
secondary) were also seen more in patients with FHE (51% vs 36%, p value <0.05). Abnormal EEG was also
seen more in patients with FHE (79% vs 66%, p < 0.05). Multivariate regression analysis showed that
temporal epileptic discharges were the best predictor for the presence of FHE (p < 0.05, OR = 3.1, 95% CI
1.7–5.8), more than idiopathic epilepsy or younger age at epilepsy onset.
Conclusions: FHE has a signiﬁcant impact on epilepsy, its classiﬁcations, and the EEG ﬁndings, and may
underlie the presence of a genetic etiology, which could be related to a high incidence of consanguinity
seen in our population. Temporal epileptic discharges were the best predictor for FHE, which may
suggest the presence of familial TLE.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is the most common neurological condition,
affecting more than 50 million people in the world, with a 3%
risk of developing epilepsy across all ages.1,2 The etiologic
categories include symptomatic, cryptogenic and idiopathic.
Whereas symptomatic epilepsies are caused by a brain insult,
the causes of cryptogenic epilepsies remain elusive. On the other
hand, idiopathic epilepsies are predominantly genetic with early
onset during childhood. Recent progress in genetic analysis
revealed that most forms of epilepsy result from a combination
of genetic and acquired factors, where predominantly genetic
epilepsies account for a small fraction of all seizure disorders.3–5* Correspondence address: College of Medicine, Department of Internal Medicine,
King Khalid University, P.O. Box 641, Abha 61421, Saudi Arabia.
Tel.: +966 7 2417578; fax: +966 7 2418111.
E-mail address: Fawzi.babtain@yahoo.com
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.04.002For this reason, it is increasingly important to understand the
impact of genetic factors on the risk factors and symptoms to
ensure that proper diagnostic and treatments are provided to
these patients.
The ﬁrst step in the diagnosis of idiopathic epilepsy is a
questionnaire establishing the family history of epilepsy (FHE) on
these patients.6 Cases of seizures among the ﬁrst-degree relatives
are usually a strong indicator of predominantly genetic epilepsies.
Incidentally, the presence of FHE was associated with an increase
in the risk of seizure recurrence after a single seizure or a febrile
convulsion.7–9 Yet, the impact of FHE on epilepsy classiﬁcations,
etiology, patients’ demographics and epilepsy investigations
remains unclear and probably complex because of the heteroge-
neity of epilepsy. Certainly, there are no studies available to
evaluate the epilepsy risk factors in the southern part of Saudi
Arabia, and the role of FHE in particular.
The aim of this study is to evaluate the impact of FHE on
patients with epilepsy, which would further enhance understand-
ing epilepsy pathogenesis and etiologies in these patients.vier Ltd. All rights reserved.
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This is a retrospective study done in Asser central hospital, in
Abha, Saudi Arabia, which is the main regional hospital in Aseer
region, with a capture area of around 1.9 million people. This study
was conducted between January and June of 2012, using our
hospital’s epilepsy registry, which contains data from all patients
diagnosed with epilepsy who were evaluated in the hospital. The
patients included in this study: (a) were 15 years and older, (b) had
at least one surface electro-encephalogram (EEG), (c) had a high
resolution magnetic resonance imaging of the brain (MRI) of 1.5 T
performed in patients with suspected localization related or
unclassiﬁed epilepsies, and (d) data on family history of epilepsy is
obtained. Patients’ gender, age at the diagnosis, and age at epilepsy
onset were also determined according to the registry, and epilepsy
risk factors were identiﬁed. According to the protocol followed in
our hospital, each patients should be assessed by an adult
neurologist to obtained detailed history and perform the
neurological examinations, followed by a routine EEG and a high
resolution MRI of the brain using epilepsy protocols, with/without
gadolinium use. Epilepsy risk factors reported in the literature
were determined in our population,10,11 and a radiologist reviewed
the MRI of the brain for the studied patients.
The age at epilepsy onset, deﬁned as the age at the ﬁrst seizure,
and the age at the diagnosis were determined. Epilepsy was
classiﬁed according to etiology into idiopathic, symptomatic and
cryptogenic, using the International Classiﬁcation of Seizures
(ICES) and Epilepsies.12 Clinical data obtained by medical history,
along with EEG and MRI results were used to classify epilepsy into
generalized, focal, or unclassiﬁed (or unknown). Furthermore,
those with unclassiﬁed epilepsy should have 2 or more EEG, one of
which would be a sleep-deprived, aiming to further classify their
epilepsy type. In addition to the clinical history taking, a separate
questionnaire sheet to be ﬁlled out for each patient to document
the age at ﬁrst seizure, age at the diagnosis, the presence of FHE,
number of family members affected, parental consanguinity and
the degree of consanguinity. Patients with FHE had to go through a
further enquiry in the presence of patient’s relative attending the
clinic to ensure the validity of this information. FHE was identiﬁed
as the presence of history of epilepsy in parents, brothers, sisters orTable 1
Patient’s demographics and risk factors.
Patients with FHEa N = 113 (%) 
Men 50 (44%) 
Mean age at presentation 24 years 
Mean age at onset 15 years 
Febrile convulsion 6 (5%) 
Head trauma 2 (2%) 
CNSc infection 2 (2%) 
Vascular 7 (6%) 
MCDd 2 (2%) 
Other structural lesions 1 (1%) 
Perinatal insults 2 (2%) 
Congenital malformation 3 (3%) 
Abnormal brain MRIe 26 (23%) 
Abnormal EEGf 89 (79%) 
Speciﬁc EEG abnormalities
Generalized discharges 38/89 (43%) 
Temporal discharges 39/89 (44%) 
Extra-temporal discharges 12/89 (13%) 
a FHE, family history of epilepsy.
b NS, non-signiﬁcant.
c CNS; central nervous system.
d MCD, Malformation of cortical development.
e MRI magnetic resonance imaging.
f EEG, electro-enecephalogram.siblings, or a second degree relative in patients with parental
consanguinity. Those patients with FHE were identiﬁed, and their
clinical, electrical and radiological data, as well as epilepsy
classiﬁcations were compared to those with no FHE.
3. Data analysis
Contingency tables and Fisher exact test were used for
statistical analysis (x2 test for categorical variables), and Student’s
t-test were used for continuous variables, and p value of <0.05 was
considered signiﬁcant. Multivariate regression analysis was
performed (binary logistic regression) to predict the variables
associated with the presence of family history of epilepsy. These
factors were; the age at epilepsy onset, the gender, epilepsy
classiﬁcation according to etiology, MRI and EEG ﬁndings. Because
of multiple testing was done, Bonferroni adjustment was
performed, and the adjusted p value of <0.00625 was used to
determine the signiﬁcance for the tested factors in the regression
analysis. The odds ratios and 95% CI were obtained. Data analysis
was performed using IBM SPSS Statistics for Macintosh, Version
20.0.0, IBM Corp., Armonk, NY.
No consent is required in our hospital to perform retrospective
studies.
4. Results
A total of 480 patients were considered for this study. Sixty
patients were excluded due to incomplete EEG or MRI documen-
tation preventing adequate epilepsy classiﬁcation. 420 patients
were included in the study, 205 (49%) were men. The mean age at
disease onset was 19 years (range: 0–85; SD = 14.7), and the mean
age at diagnosis was 27 years (range: 15–85 years; SD 14.1).
Epilepsy was found to be idiopathic in 140 patients (33%),
symptomatic in 152 (36%), and cryptogenic in 128 patients
(30%). According to seizure onset, 196 patients (46%) had partial
epilepsy, 169 (40%) had generalized, and unclassiﬁed epilepsy was
only seen in 55 patients (13%). MRI of the brain was abnormal in
128 patients (30%), and EEG showed epileptic discharges in 293
patients (70%), where it was generalized in 104 patients (25%), and
temporal or extra-temporal in 189 patients (45%). Table 1 showsPatients with no FHE N = 307 (%) p-Valueb
155 (51%) NSb
28 years 0.026
20 years 0.005
15 (5%) NS
18 (6%) NS
10 (3%) NS
39 (13%) NS
3 (1%) NS
9 (3%) NS
17 (6%) NS
7 (2%) NS
98 (32%) NS
204 (66%) 0.015
66/204 (32%) NS
94/204 (46%) NS
44/204 (22%) NS
Fig. 1. Distribution of identiﬁed epilepsy risk factors (N = 420). Legend: & = no risk
factors; = family history of epilepsy; = vascular disease; = febrile
convulsion; & = head trauma; = birth related injuries; = miscellaneous
brain lesions; = CNS infection; and = malformation of cortical development.
Fig. 2. Distribution of epilepsy classiﬁcations (A) and etiologies (B) between the two
groups. Legend: = epilepsy with family history and & = epilepsy with absent
family history.
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ly classiﬁed, and all three categories of epilepsy were well
represented in this subject cohort.
The present study considered all major risk factors of epilepsy,
namely FHE, vascular disease, birth related injuries, febrile
convulsion, head trauma, miscellaneous brain lesions, central
nervous system (CNS) infection, and abnormal cortical develop-
ment. Surprisingly, 45% of the patients did not present any of these
risk factors (Fig. 1). The most common risk factor was FHE (27%),
followed by vascular disease (11%). All other risk factors were
noted in 1–5% of the patients, for a total prevalence of 24%. Also, the
total amounted to 107%, which means that some patients exhibited
more than one risk factor.
Since FHE constitutes the most common risk factor, we
compared the characteristics of patients with or without FHE
(Table 1). Patients with FHE were signiﬁcantly younger by 4–5
years at the time of diagnosis and at the disease onset (p < 0.05).
Epilepsy risk factors were distributed between both groups with no
particular patterns, and similar prevalence of abnormal MRI was
observed between the groups.
4.1. Family history inﬂuences seizure semiology and etiology (Fig. 2)
Classiﬁcation of the different types of epilepsy for FHE and non-
FHE patients revealed that the existence of siblings with epilepsy
might inﬂuence the type of epilepsy that an individual may
develop. Fig. 2A shows that FHE was associated with a 15% higher
prevalence of generalized seizures (51% vs 36%, p = 0.005), while
there were trends for observing unclassiﬁed epilepsy less across
patients with FHE (8% vs 15%, p = 0.06). In addition, idiopathic
epilepsy was encountered 13% more often in the FHE group than in
the non-FHE patients (43% vs 30%, p = 0.008; Fig. 2B), which would
support an impact of genetic markers on the type of epilepsy, and
provides new information on the characteristics of FHE patients.4.2. Family history inﬂuences MRI and EEG
Detailed analysis of the MRI ﬁndings revealed differences
between the patients with or without FHE (Table 2). Epileptic
patients with FHE manifested hippocampal atrophy with mesial
temporal sclerosis (MTS) on MRI of the brain signiﬁcantly more
than those with no FHE (38% vs 10%, p < 0.05), but were found to
have less ischemic changes than patients lacking FHE (19% vs 41%,
p < 0.05). These data suggest that hippocampal atrophy plus MTS,
in the absence of ischemic changes, may be a strong indictor of
epileptic patients with FHE.
Epileptic patients with FHE had 13% more abnormal EEG
recording than patients with no FHE (79% vs 66%, p < 0.05), and the
temporal discharges were the most prevalent changes observed in
both groups. There were no particular EEG patterns associated
with FHE (Table 1).
4.3. Predicting the presence of family history of epilepsy
Multivariate regression analysis was performed to identify
predictors of FHE in patients with epilepsy. Table 3 summarizes
results of logistic regression analysis for the tested variables.
Cryptogenic epilepsy was excluded from the regression model by
SPSS. Epileptic patients with temporal epileptic discharges
observed in EEG are three times more likely to have a family
member with epilepsy irrespective of structural temporal changes
Table 2
Identiﬁed brain MRI ﬁndings across the groups.
Patients with FHE N = 26 (%) Patients with no FHE N = 98 (%) p-Value
Hippocampal atrophy with/without MTSa 10 (38%) 10 (10%) 0.0005
Ischemic changes 5 (19%) 40 (41%) 0.042
ICHb – 1 (1%) NS
Vascular malformation 1 (4%) 4 (4%) NS
Malformations of cortical development 2 (8%) 3 (3%) NS
Arachnoid cyst 2 (8%) 6 (6%) NS
Birth related injury 2 (8%) 16 (16%) NS
Cerebral contusion – 7 (7%) NS
Non-speciﬁc white matter 2 (8%) 6 (6%) NS
Leukodystrophy – 1 (1%) NS
Tuberculoma 1 (4%) – NS
Congenital hydrocephalus – 1 (1%) NS
Post-meningeo-encephalitis changes – 3 (3%) NS
Dandy Walker malformation 1 (4%) – NS
a Mesial temporal sclerosis.
b Intracerebral hemorrhage.
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of FHE in epileptic patients (Bonferroni adjusted p value <0.00625,
OR = 3.1, 95% CI 1.7–5.8). These ﬁndings may suggest the presence
of partial familial epilepsy in our population, particularly temporal.
Despite the signiﬁcant p values of less than 0.05 obtained for
idiopathic epilepsy (p = 0.01, OR = 2.0, 95% CI 1.2–3.4) and younger
age at epilepsy onset (p = 0.02, OR = 0.98, 95% CI 0.96–0.99) in our
regression model, the Bonferroni adjusted p values were insigniﬁ-
cant for which they could not be used as predictors of the presence
of FHE. Other factors such as epilepsy etiologies other than
idiopathic, EEG patterns or MRI ﬁndings could not also predict the
presence of FHE in patients.
5. Discussion
Predominantly genetic epilepsies account for a small fraction of
all seizure disorders.3 For this reason, it has been difﬁcult to
acquire reliable information on the symptoms of these patients to
ensure proper diagnosis and treatment. A detailed family history is
of great value in evaluating patients with epilepsy to determine
whether genetic factors contribute to its etiology. In the present
study, one forth of the patients with epilepsy has FHE of variable
etiologies, similar ﬁndings to that reported in Jordanian children
with epilepsy,13 but 3–4 folds higher rate than in other
countries.14–16 This may be related to a high incidence of
consanguineous marriage reported in the region.17 Nearly half
of our patients with idiopathic epilepsy had FHE. An earlier study
reported a high incidence of FHE in patients with juvenile
myoclonic epilepsy.18 The availability of such a large group ofTable 3
Predictors of the presence of family history of epilepsy (FHE) using logistic regression 
Predictor RCa SEb
Age at the disease onset 0.208 0.14 
Gender 0.269 0.230 
Epilepsy classiﬁcation
Idiopathic 0.540 0.373 
Symptomatic 0.334 0.313 
EEG patterns
Generalized 0.348 0.347 
Temporal 1.146 0.344 
Extra-temporal 0.119 0.493 
The presence of normal MRI of the brain 0.408 0.261 
a Regression coefﬁcient.
b Standard error.
c Bonferroni adjusted signiﬁcant p value <0.00625.epileptic patients in a region with high incidence of consanguine-
ous marriage was a unique opportunity to investigate how FHE
affects the etiology and diagnosis of patients with epilepsy.
The role of parental consanguinity in epilepsy was evaluated in
the literature, aiming to determine whether it is a risk factor for
epilepsy. Asadi-Pooya examined unrelated Iranian children with
epilepsy and found a signiﬁcantly higher percentage of parental
consanguinity in these patients when compared to general
population, and he concluded that parental consanguinity was a
potential risk factor for epilepsy.19 On the other hand, Khan found
no association between parental consanguinity and epilepsy in a
population known to have high rates of this marital habit, yet FHE
was documented in more than half of the cases.20 FHE was found to
be a strong predictor of epilepsy in a population-based case–
control study by Kannoth, and it increased the risk to develop both
generalized and localization related epilepsies. To the contrary,
parental consanguinity was not a predictor of epilepsy in that
study despite their signiﬁcant presence among patients with
epilepsy.21 The aforementioned studies conﬁrmed the crucial role
played by FHE in developing epilepsy irrespective of parental
consanguinity, which would suggest rather multifactorial etiolo-
gies contributing to the development of epilepsy. Although our
study did not aim to identify whether FHE is a risk factor for
epilepsy, it rather presented interesting characteristics observed in
epileptics with FHE, and with the questionable role of parental
consanguinity, our ﬁndings might be applicable to other popula-
tion with unknown or low prevalence of parental consanguinity.
While predominantly genetic epilepsies constitute a minority
of all seizure disorders, the etiology of epilepsy combines acquiredanalysis.
Wald statistic p-Value Odds ratio (95% CI)
4.060 0.02 0.98 (0.96–0.99)
1.376 0.25 1.3 (0.8–2.0)
2.098 0.01 2.0 (1.2–3.4)
1.136 0.29 0.8 (0.4–1.3)
1.005 0.29 1.4 (0.7–2.8)
11.075 0.001c 3.1 (1.7–5.8)
0.058 0.17 0.4 (0.2–0.9)
2.448 0.28 1.4 (0.8–2.4)
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any age, depending on the impact of the genetic drivers. For
instance, benign familial neonatal seizures are detected soon after
birth, with no structural brain abnormalities and a variable
prognosis.22,23 In our study, the mean age at seizure onset of the
patients with FHE was 15 years, compared to 20 years for non-FHE
patients. While these patients were young adults, nearly half of
them were diagnosed with idiopathic epilepsy, compared to only
30% for non-FHE epileptic patients. Therefore, the inﬂuence of
acquired factors is undeniable, but the genetic drivers were
sufﬁciently strong to signiﬁcantly alter the timeline of the disease.
The role of FHE in symptomatic or cryptogenic epilepsies is
unclear, although one small series found that FHE was associated
with a younger age at onset in cases with cortical dysplasia.24
Another study reported a signiﬁcant association not only between
FHE and idiopathic epilepsy but also with cryptogenic epilepsy.16
The association between FHE and symptomatic and cryptogenic
epilepsies is likely to be of a lesser importance compared to
idiopathic epilepsy.
Since FHE detects patients whose disease is inﬂuenced by
genetic factors, this study allowed us to visualize the impact of
genetic mutations on brain damage in epileptic patients, where
we observed the abnormal EEG (either generalized or temporal or
extra-temporal) more in our patients with epilepsy and FHE
(Table 1). This epileptogenic effect of FHE goes with the fact that
FHE is associated with an increased risk of seizure recurrence
following a single unprovoked seizure,7,25 and hence these
patients might need a longer duration on treatment than those
with no FHE.26 Despite the fact that EEG discharges characteristic
of idiopathic epilepsy were seen more in patients with FHE, these
changes were not particularly associated with FHE in our
population. Documenting secondary generalized EEG discharges
in patients with FHE might be related to the presence of other
hereditary secondary generalized epilepsy. Temporal epileptic
discharges were the most common identiﬁed EEG abnormalities
documented in our studied population, irrespective of FHE, and
interestingly were the best predictor for FHE in our group. With
the high prevalence of temporal atrophy with/without MTS in our
patients with FHE, familial temporal lobe epilepsy would be
suggested. Variable chromosomal linkage had been identiﬁed in
cases with familial temporal lobe epilepsy (TLE), and family
studies of post-operative cases in Montreal Neurological Institute
suggested a complex inheritance.27–30 In these cases, febrile
convulsion was less frequently observed when compared to
random surgical cases,31,32 and seizure onset is usually late.33 Yet,
the prognosis is variable in these cases, particularly in those with
hippocampal atrophy, where surgical treatment was required to
achieve seizure control.34 Since temporal EEG discharges were the
most predictor for FHE, familial TLE should be considered in our
population. Furthermore, determining genetic TLE requires
documenting TLE in two family members, but haplotype analysis
or speciﬁc molecular testing could conﬁrm the diagnosis.35
MRI of the brain is central in investigating patients with
epilepsy,36–38 with variable sensitivities to detect epileptogenic
lesions across studies,39,40 although the majority of patient will
have non-lesional epilepsy. The correlations between FHE and MRI
ﬁndings has not been evaluated in the literature in which one may
predict prognosis after a single seizure or following withdrawal of
antiepileptics. Despite the lack of a signiﬁcant association between
the presence of MRI abnormality and FHE, speciﬁc MRI lesions such
as hippocampal atrophy with mesial temporal sclerosis were
signiﬁcant ﬁndings in epileptics with FHE. These observations
could be explained by the fact that these patients experienced
febrile convulsions more than those with no FHE (Table 1). Another
reason would be the possibility of familial TLE as suggested
previously. On the other hand, MRI lesions consistent withischemic changes were signiﬁcantly seen more in patients lacking
FHE, and other identiﬁed MRI abnormalities were 2-folds more
likely to be seen in epileptics with absent FHE (Table 2). The
presence or absence of MRI abnormalities could not predict FHE in
patients with epilepsy.
Our study had some limitations. This study was conducted only
in adult population with epilepsy. Including pediatric patients may
strengthen the validity of the data, particularly when we are
analyzing the role of FHE on epilepsy, which may be present more
in pediatric population with different genetic epilepsies where FHE
will play an important role. Nonetheless, the data on the impact of
FHE on epilepsy are scare for which this study will provide useful
information to help in the understanding of this association, and
guide the clinicians during the evaluation of epileptic patients with
a suspected genetic etiology.
6. Conclusions
The presence of FHE in epileptic patients has a signiﬁcant
impact on epilepsy classiﬁcations and the underlying etiology,
EEG ﬁndings, along with the age at the diagnosis and at the
disease onset. The signiﬁcant association between idiopathic
epilepsy and the presence of FHE suggests its role in genetic
epilepsy, and the surprisingly higher incidence of temporal
atrophy with MTS in MRI brain, along with the strong predictive
role of temporal EEG discharges raises the suspicion for familial
TLE. The higher rates of consanguineous marriages reported in
our population probably contributes to the genetic epilepsy
types encountered. The assessment of FHE in newly diagnosed
cases with epilepsy is crucial step in classifying epilepsy and
determining an etiology.
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